Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine
Knutson, Keith L., Block, Matthew S., Norton, Nadine, Erskine, Courtney L., Hobday, Timothy J., Dietz, Allan B., Padley, Douglas, Gustafson, Michael P., Puglisi-Knutson, Danell, Mangskau, Toni Kay, ChJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-2123
Date:
November, 2019
File:
PDF, 899 KB
2019